EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Similar documents
Dalmia Bharat Enterprises

EBITDA 6,223 6,511 (4.4) 5, EBITDA

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

EBITDA 5,076 3, , EBITDA

Dalmia Bharat Enterprises

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

Dalmia Bharat Enterprises

Institutional Equities

The Ramco Cements. Institutional Equities. Event Update BUY

Indian Oil Corporation

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Jamna Auto Industries

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Gillette India. Institutional Equities. 1QFY18 Result Update

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Colgate-Palmolive (India)

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Punjab National Bank

Indian Oil Corporation

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Institutional Equities

Institutional Equities

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Punjab National Bank

Institutional Equities

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Institutional Equities

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

EBITDA 5,019 4,211 5, EBITDA

Institutional Equities

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

3,746 2,551 3, NIM

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Bharat Financial Inclusion

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Institutional Equities

Institutional Equities

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

2,09,057 1,85,859 2,17, (4.1) NIM

Institutional Equities

Dabur India. Institutional Equities. 1QFY19 Result Update

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

9,500 7,914 8, NIM

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

18,948 15,784 18, NIM

93,707 77,814 90, NIM

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Punjab National Bank

Initiating Coverage. Uflex Ltd.

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Institutional Equities

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Punjab National Bank

Institutional Equities

E&P To Stay Strong; Consumer Segment To Revive

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Institutional Equities

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Institutional Equities

Punjab National Bank

9,251 7,812 8, NIM

9,807 8,007 9, NIM

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Institutional Equities

Operating expenses tracked lower than core total income growth as ABL displayed continued

Institutional Equities

Federal Bank. Institutional Equities. Management Meet Update

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

State Bank of India. Institutional Equities. 1QFY18 Result Update

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

Cement Sector 6 June 2018

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Robust results, TLT margins improved profitability.

Cement Sector 27 February 2018

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Transcription:

1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance driven by steady realisation (marginal decline), despite strong volume growth. Revenues grew ~19% YoY to 2.61mnmt (above our estimate of 2.47mnmt) driven by healthy demand from the eastern region and recovery in TRCL s key markets like Tamil Nadu (TN). Realisation marginally declined by ~1.5% YoY to Rs4,537/tn, despite strong volume growth because of the judicious sales mix in core markets and new regions. Cost escalation because of higher energy and logistics costs contributed to operating cost inflation of ~% YoY at Rs3,79/tn. Limited pass- through led to EBITDA margin compression of 771bps YoY (partially because of a higher base) to 2.5% YoY. EBITDA fell 13.8% to Rs2.5bn and EBITDA/tn declined ~3% YoY to Rs919from Rs958. Debt repayment helped lower interest expense by 26% YoY to Rs114mn. Incentives from the new Vizag unit (in FY18) contributed to higher operating income of Rs339mn. Effectively, adjusted PAT fell ~2% YoY to Rs1.25bn. We have valued TRCL at a replacement cost of Rs 11.7bn/mt assigned to its operating capacity of 16.6mt (based on the expanded FY2E clinker capacity) and the excess grinding capacity (4mt based on FY2E capacity) at Rs1.75bn to arrive at a target price of Rs813 (revised from Rs894 earlier). We have assigned ~5% premium to the operating capacity to arrive at TRCL s fair value as we strongly believe the performance will revive and boost earnings following the recovery in its key markets, structural strength by focusing on regional diversification (eastern region) and cost tightening measures. The current weakness is temporary (because of combination of weak realisation and escalated costs) and will fade away as the core market demand revives. We have retained our Buy rating on TRCL. At our target price, the stock trades at an EV/EBITDA of 13.5x FY2E earnings. Volume growth continues: Volume jumped 22% YoY to 2.61mnmt following strong demand in the eastern region and recovery in TRCL s core market (TN)in1QFY19. Despite this, the realisation dipped only marginally by 1.5% to Rs4,537/tn owing to a judicious sales mix. Cost inflation and limited pass-through impacts EBITDA margin: Energy costs (adjusted to raw material costs) rose ~12% YoY on account of high pet-coke usage (65% in 1QFY19). Logistics costs were up ~21% YoY to Rs1,123/tn because of higher diesel prices and higher lead distance (to be reverted back to normal). However other expenditure was controlled at Rs1.57bn, despite strong volume jump and higher promotional expenses (in the eastern region). Despite this, operating costs rose % YoY to Rs3,79/tn. However, limited pass-through of cost inflation because of demand weakness in key market (TN) led to compression in EBITDA margin by 771ps YoY to 2.5%. Maintain our estimates: Despite the weak performance in 1QFY19, we have maintained our earning estimates of Rs33.9/Rs41.5 for FY19/FY2, respectively. This is factoring in the demand revival in key TN market, sustained recovery in Andhra Pradesh, logistic cost savings (truck-loading norm and new grinding units) and strong cost control measures. Outlook: We have valued TRCL at a replacement cost of Rs11.7bn/mt assigned to its operating capacity of 16.6mt (based on the expanded FY2E clinker capacity) and the excess grinding capacity (4mt based on FY2Ecapacity) at Rs1.75bn to arrive at the target price of Rs813 (revised from Rs894 earlier). We have assigned ~5% premium to the operating capacity to arrive at TRCL s fair value. We have retained Buy rating on the stock At our target price, the stock trades at an EV/EBITDA of 13.5x FY2E earnings. NBIE Values your patronage- Vote for The Team in the Asia Money poll 218. Click Here BUY Sector: Cement CMP: Rs679 Target Price: Rs813 Upside: 2% Milind Raginwar Research Analyst milind.raginwar@nirmalbang.com +91-22-6273 8172 Key Data Current Shares O/S (mn) 235.6 Mkt Cap (Rsbn/US$bn) 16.2/2.3 52 Wk H / L (Rs) 879/615 Daily Vol. (3M NSE Avg.) 369,84 Price Performance (%) 1 M 6 M 1 Yr The Ramco Cements (3.4) (7.7) (1.2) Nifty Index 6.2 5.6 13.5 Source: Bloomberg Y/E March (Rsmn) 1QFY19 YoY % QoQ % Net sales 12,199,288 18.6 12,548 (2.8) Operating expenses 9,696. 7,272.8 33.3 9,729.7 (.3) EBITDA 2,53 2,94 (13.8) 2,722 (8.) EBITDA margin (%) 2.5 28.2 (771bps) 21.7 (117bps) Other Income 49 52 (6.1) 19 (74.1) Interest costs 114 155 (26.) 5 9.4 Depreciation 735 72 2. 754 (2.6) PBT 1,73 2,82 (18.2) 2,53 (17.) Non-recurring items - - - (288) - PBT (after non-recurring items) 1,73 2,82 (18.2) 1,765 (3.5) Tax 453 524 (13.5) 679 (33.2) Reported PAT 1,25 1,558 (19.8) 1,86 15.1 Adjusted PAT 1,25 1,558 (19.8) 1,374 (9.1) NPM (%).2 15.1 (49bps) 11. (71bps) Adjusted EPS (Rs) 5.3 6.5 (19.) 5.8 (9.1) Source: Company, Nirmal Bang Research

Exhibit 1: Operational details (Rs) 1QFY19 YoY % QoQ % 1QFY19E Deviation % Volume (mnmt) 2.61 2.15 21.6 2.74 (4.5) 2.47 5.7 Cement realisation (net of freight) (Rs/mt) 4,537 4,67 (1.5) 4,567 (.7) 4,467 1.6 Operating costs (Rs/mt) 3,79 3,383 9.7 3,556 4.3 3,481 6.6 EBITDA (Rs/mt) 919 1,34 (29.5) 958 (4.1) 974 (5.6) Source: Company, Nirmal Bang Research Exhibit 2: Detailed quarterly financials (Rsmn) 1QFY19 YoY % QoQ % 1QFY19E Deviation % Net sales 12,199,288 18.6 12,548 (2.8) 11,183 9.1 Expenditure Change in stock (234.4) (27.8) 12.8 31.6 (841.8) (55.) 326.2 Raw material costs 2,42 1,688 21. 2,185 (6.5) 1,953 4.5 Purchased products - - - - - - - Power & fuel expenses 2,563 1,681 52.4 2,176 17.8 1,978 29.6 Freight costs 2,935 1,999 46.8 2,912.8 2,547 15.2 Employee costs 82 749 9.4 738 11.1 725 13. Other exp 1,571 1,363 15.3 1,687 (6.9) 1,458 7.7 Total operating expenses 9,696 7,273 33.3 9,73 (.3) 8,66 12.7 EBITDA 2,53 2,94 (13.8) 2,722 (8.) 2,58 (.2) EBITDA margin (%) 2.5 28.2 (771bps) 21.7 (117bps) 22.4 (191bps) Other income 49 52 (6.1) 19 (74.1) 55 (.5) Interest costs 114 155 (26.) 5 9.4 2 12.2 Depreciation 735 72 2. 754 (2.6) 745 (1.4) PBT 1,73 2,82 (18.2) 2,53 (17.) 1,716 (.7) Non-recurring items - - - (288) (.) - - PBT (after non-recurring items) 1,73 2,82 (18.2) 1,765 (3.5) 1,716 (.7) Tax 453 524 (13.5) 679 (33.2) 429 5.7 Tax rate (%) 27 25 6bps 38 (31bps) 25 6bps Reported PAT 1,25 1,558 (19.8) 1,86 15.1 1,287 (2.9) Adjusted PAT 1,25 1,558 (19.8) 1,374 (9.1) 1,287 (2.9) NPM (%).2 15.1 (49bps) 11. (71bps) 11.5 (126bps) Adjusted EPS (Rs) 5.3 6.5 (19.) 5.8 (9.1) 5.5 (2.9) Source: Company, Nirmal Bang Research Exhibit 3: Trend in operating costs/mt Operating costs/mt(rs) 1QFY19 YoY % QoQ % Consumption of raw material 786 741 83 749 688 722 914 8 692.5 (14.6) Power and fuel costs 623 591 645 68 782 82 751 795 98 25.4 23.3 Freight costs 853 879 891 91 93 979 995 1,64 1,123 2.7 5.5 Total costs per mt 3,196 3,224 3,362 3,277 3,383 3,573 3,641 3,556 3,79 9.7 4.3 Source: Company, Nirmal Bang Research 2 The Ramco Cements

Exhibit 4: Estimates Maintained Old estimates New estimates Change (%) (Rsmn) FY19E FY2E FY19E FY2E FY19E FY2E Net sales 51,5 56,878 51,5 56,878 - - Operating profit 12,777 14,918 12,777 14,918 - - Net profit 7,98 9,788 7,98 9,788 - - EPS (Rs) 33.9 41.5 33.9 41.5 - - Target price (Rs) 894 813 Rating BUY BUY Source: Company, Nirmal Bang Research 3 The Ramco Cements

4QFY15 1QFY19 1QFY19 4QFY15 1QFY19 1QFY19 Exhibit 5: New regional expansion boosts volume 3. 2.74 2.614 6 2.5 2.9 2.8 2.3 1.99 2.28 2.15 2.15 2.27 5 2. 1.81 1.71 1.63 4 1.5 3 1. 2.5. (.5) () (1.) (2) Exhibit 6: Realisation pressure continues due to lack of support from core markets 5, 2 4,75 4,5 4,25 4, 3,75 3,5 15 5 (5) () (15) Volumes (mn mt) Realisations (Rs/mt) Source: Company, Nirmal Bang Research Exhibit 7: Performance impacted because of limited cost pass-through Source: Company, Nirmal Bang Research Exhibit 8: Cost escalation aided by high energy and logistics costs (Rsmn) 1,7 1,5 1,3 1, 9 7 5 3 1,529 1,554 1,486 1,493 1,417 1,431 1,288 1,34 1,319 1,145 936 958 919 3,8 15 3,7 3,6 3,5 5 3,4 3,3 (5) 3,2 () 3, 3, (15) 2,9 (2) 2,8 (25) EBITDA/mt Operating costs/mt (Rs) Source: Company, Nirmal Bang Research Exhibit 9: Higher lead distance pushes up logistics costs 1,2 2 1, 15 8 5 6 4 (5) () 2 (15) - (2) Source: Company, Nirmal Bang Research Exhibit : Higher fuel cost inflation pushes up energy expenses 1, 4 9 3 8 7 2 6 5 4 () 3 2 (2) (3) - (4) Freight costs/mt (Rs) Power & Fuel costs/mt (Rs) Source: Company, Nirmal Bang Research Source: Company, Nirmal Bang Research 4 The Ramco Cements

Apr-8 Aug-8 Jan-9 Jun-9 Nov-9 Mar- Aug- Jan-11 Jun-11 Oct-11 Mar-12 Aug-12 Jan-13 May-13 Oct-13 Mar-14 Aug-14 Dec-14 May-15 Oct-15 Mar-16 Aug-16 Dec-16 May-17 Oct-17 Mar-18 Jul-18 Apr-8 Aug-8 Jan-9 Jun-9 Nov-9 Mar- Aug- Jan-11 Jun-11 Oct-11 Mar-12 Aug-12 Jan-13 May-13 Oct-13 Mar-14 Aug-14 Dec-14 May-15 Oct-15 Mar-16 Aug-16 Dec-16 May-17 Oct-17 Mar-18 Jul-18 Exhibit 11: Valuation charts EV/EBITDA (Rs) 1, 8 6 4 EV/tn (Rs) 8 6 4 2 2 Price 8 12 14 Source: Company, Nirmal Bang Research Price $8 $ $12 $14 $16 Source: Company, Nirmal Bang Research 5 The Ramco Cements

Financials Exhibit 12: Income statement Year Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY2E Net sales 35,517 39,32 44,64 51,5 56,878 Growth (%) (1.2).7 12.1 15.8 11.5 Operating expenses (25,17) (27,731) (33,142) (38,228) (41,96) EBITDA,51 11,571,922 12,777 14,918 Growth (%) 58.6.2 (5.6) 17. 16.8 Depreciation & amortisation (3,48) (2,655) (2,922) (2,73) (2,575) EBIT 8,552 9,537 8,366,915 13,222 Other income 1, 621 366 84 879 Interest paid (1,819) (1,35) (592) (584) (573) Extraordinary/exceptional items PBT 6,734 8,51 7,774,331 12,649 Tax (1,312) (2,9) (2,29) (2,351) (2,861) Effective tax rate (%) (19.5) (23.6) (29.5) (22.8) (22.6) Net profit 5,422 6,493 5,484 7,98 9,788 Minority interest - - - - - Reported net profit 5,422 6,493 5,484 7,98 9,788 Non-recurring items - - - - - Adjusted net profit 5,422 6,493 5,484 7,98 9,788 Growth (%) 123.7 19.8 (15.5) 45.5 22.6 Source: Company, Nirmal Bang Research Exhibit 14: Balance sheet Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY2E Cash & bank balances 98 1,181 1,127 1,234 1,342 Other current assets 13,838 14,392 11,789 2,876 25,973 Investments 1,442 1,483 2,168 2,172 2,173 Net fixed assets 52,116 52,395 54,927 51,223 57,185 Goodwill & intangible assets 638 638 827 1,67 1,37 Other non-current assets - - - - - Total assets 68,942 7,88 7,836 76,572 87,978 Current liabilities 13,998 14,731 13,18 12,63 13,384 Borrowings 16,854 11,496 9,989 8,629 9,829 Other non-current liabilities 7,155 7,281 7,597 8,97 8,597 Total liabilities 38,7 33,59 3,766 29,356 31,8 Share capital 238 238 236 236 236 Reserves & surplus 3,697 36,341 39,835 46,98 55,932 Shareholders' funds 3,935 36,579 4,7 47,215 56,168 Minority interest - - - - - Total equity & liabilities 68,942 7,88 7,836 76,572 87,978 Source: Company, Nirmal Bang Research Exhibit 13: Cash flow Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY2E Pre-tax profit 6,734 8,51 7,774,331 12,649 Depreciation 3,89 2,347 4,91 4,158 4,221 Chg in working capital 447 2 (1,55) (9,913) (4,853) Total tax paid (1,269) (1,882) 22 (1,575) (1,851) Other operating activities - - - - - Operating CF 9, 9,68,337 3,2,166 Capital expenditure (2,344) (2,625) (6,812) (694) (,423) Chg in investments 24 (42) (684) (4) (1) Other investment activities - - - - - Investing CF (2,319) (2,667) (7,496) (698) (,424) FCF 6,681 6,41 2,841 2,33 (257) Equity raised/(repaid) - - (3) - - Debt raised/(repaid) (5,235) (5,358) (1,57) (1,36) 1,2 Dividend (incl. tax) (1,395) (757) (231) (835) (835) Other financing activities (2) (13) (1,155) - - Financing CF (6,65) (6,128) (2,895) (2,195) 365 Net chg. in cash & bank bal. 31 273 (54) 8 7 Closing cash & bank bal. 98 1,181 1,127 1,234 1,342 Source: Company, Nirmal Bang Research Exhibit 15: Key ratios Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY2E Profitability and return ratios (%) EBITDAM 29.6 29.4 24.8 25.1 26.2 EBITM 24.1 24.3 19. 21.4 23.2 NPM 15.3 16.5 12.4 15.6 17.2 RoE 18.8 19.2 14.3 18.3 18.9 RoCE 15.4 17.3 14.8 18. 19.1 RoIC 13. 13.8 11. 14.7 15.5 Per share data (Rs) O/s shares 238.1 238.1 236.9 235.6 235.6 EPS 22.8 27.3 23.2 33.9 41.5 FDEPS 22.8 27.3 23.2 33.9 41.5 CEPS 35.6 38.4 35.5 45.3 52.5 BV 129.9 153.6 169.2 2.4 238.4 DPS 4.5 3. 3. 3. 3. Valuation ratios (x) PE 29.8 24.9 29.3 2. 16.3 P/BV 5.2 4.4 4. 3.4 2.8 EV/EBITDA 16.9 14.9 15.6 13.2 11.4 EV/Sales 5. 4.4 3.9 3.3 3. Other key ratios D/E (x).5.3.2.2.2 DSO (days) 49 52 37 46 47 DuPont analysis - RoE NPM (%) 15.3 16.5 12.4 15.6 17.2 Asset turnover (x).5.6.6.7.7 Leverage factor (x) 2.4 2.1 1.8 1.7 1.6 RoE (%) 18.8 19.2 14.3 18.3 18.9 Source: Company, Nirmal Bang Research 6 The Ramco Cements

Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 218 Buy 796 887 24 May 218 Buy 798 894 6 June 218 Buy 746 894 3 August 218 Buy 679 813 Rating track graph 9 85 8 75 7 65 6 55 5 Not Covered Covered 7 The Ramco Cements

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 214 having Registration no. INH1436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I/We, Milind Raginwar, the research analysts is the author of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 8 The Ramco Cements

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and noninfringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 3926 817 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 3926 823, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 3926 8/81, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 3926 82/83, +91 22 6636 883 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 31/32, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-413. Board No. : 91 22 6273 8/1; Fax. : 22 6273 8 9 The Ramco Cements